Jenn Wieworka

Incredible, inspiring, and exhausting trip to San Antonio for the 51st annual Oncology Nursing Society Congress. I have been an oncology nurse for 20 years and still continue to learn everyday; this year’s Congress was no exception. @IMFnurseMyeloma @JWiework

We’re lighting Columbia Center RED to honor the strength of those impacted by multiple myeloma and to raise awareness during #MyelomaActionMonth. Standing in solidarity with the global myeloma community and @IMFmyeloma.

ICE Agents SMASH the window of an activists car, pull him out and detain him as protesters confront the federal agents on the streets in Southside Minneapolis

@IMFmyeloma @jmikhaelmd @IMFsupport Replay available now! myeloma.org/videos/multipl… #IMFASH25 #ASH25

In one hour, join us LIVE! Together our Support Group Leaders, an NLB member, and our Chief Medical Officer to give you the highlights from #ASH25. facebook.com/events/8372375… #IMFASH25 #mmsm @jmikhaelmd @IMFsupport

What’s New in Myeloma Research? Join our speakers online on Wednesday, January 7, 2026, to hear about the top myeloma research presented at ASH— all from a patient perspective. Register before spots are gone: mmsm.link/4pOxSz1 #IMFASH25 #ASH25 #mmsm

@SagarLonialMD @EricWolf_USMC with our #IMFASH25 meeting with GSK this AM, the things that they couldn't speak to is current trials, like DREAMM-8 where they are looking at how to get quality ocular monitoring while reducing patients visits. #ASH25

We're excited to have belantamab back; DREAMM-8 showed ↑ monitoring ↓ ocular toxicities. @SagarLonialMD shared that using eye specialists + in office Snellen eye charts and PROs may be the way to monitor and reduce patient visits #MMsM #ASH25 #IMFASH25

@TomBmt133 “The best regimen for your patient is the one that both you and your patient believe are right for them!” Shared decision making thanks to many options available! #ASH25 #IMFASH25 @IMFmyeloma

@Daw6Jessie Its interesting in the Hazard Ratio, like the intermediate risk favors Dara more than the high risk. Wonder if that needs to be examined more to make sure patients are getting under treated! @ASHIMF25 #ASH25

IMWG scoring system sub-groups, PFS 4/

Aquila update: risk stratification for HRSMM has improved since Aquila accrued; post-hoc analyses conducted in 3 areas: updated risk models, age-related safety & efficacy, & stem-cell collection yield outcomes #ASH25 #IMFASH25 @IMFmyeloma 1/

@MidAtlanticMSG @TerryGlassman @IMFmyeloma @jmikhaelmd Also loving your Patient and Hope In Action badge ribbons!

#Myeloma peeps at #ASH25 @TerryGlassman and I co-facilitate the IMF’s global Living with High-Risk MM special interest group. Feel free to pass along our contact to any of your HRMM patients across the globe! HRMM@IMFsupport.org #IMFASH25 @IMFmyeloma @jmikhaelmd

@TerryGlassman @jmikhaelmd But how much hand sanitizer did you use after touching the #ASH25 holdy sign 🤣

My #ASH25 photo! I left the mask on because that’s how I roll! Absolutely love being a part of this! Thank you #internationalmyelomafoundation for always thinking of including the patients! #IMFASH25 #mmsm #myeloma @jmikhaelmd

Grateful for our opportunity to lead ⁦@IMFmyeloma⁩ incredible Myeloma@Voices at ASH team. Our coMMunity becomes faMMily and we are so honored to highlight their voices! #ASH25 #IMFASH25 ⁦@IMFsupport⁩

/5 Key Take aways, monitor ferritin for early diagnosis of IEC-HS. IEC-HS is associated with worse PFS/OS. Great things to think about in the future, how do we identify who is at risk, and how do we prevent it!

/4 A propose measure of diagnostics, Ferritin >7500 ng/ml, with the attributes denoted in Hines criteria, shows how systemically inflamed patients get.

A life-threatening complication of CAR-T tx, @TheBloodDoc & @LMikkMD presented on Immune Effector Cell-Associated Hemophagocytic Syndrome (IEC-HS). How do we prevent it, 1st providers need to be aware and dx it #ASH25 #IMFASH25 #mmsm/1

More great research from @UrviShahMD & team about the impact of nutrition on precursor conditions (MGUS & SMM), published yesterday! aacrjournals.org/cancerdiscover…

@blondie1746 @MidAtlanticMSG @Daw6Jessie @IMFsupport @IMFmikeMYELOMA @EricWolf_USMC @TerryGlassman @PetalResilient @Jmikhael @IMFnurseMyeloma @salmon_rob @JimJhs17 @IMFmyeloma @Jay_Gee_El

Remember this exciting headline from June? CARTITUDE-1 5 year f/u with 33% PFS for ≥ 5 yrs and ~1/2 had 5 year OS. @End_myeloma compares to CARTITUDE-4, pts were treated in earlier lines, having < BCMA fatigue, ↓ COVID rates. Data is even more HOPEFUL! #MMsM #ASH25 #IMFASH25

@MyelomaTeacher It was pretty shocking to hear, only occurring in 2% of patient but a 40% mortality for those that get it! Glad they’ve identified this toxicity and can start addressing early

Newly identified CAR-T toxicity- immune effector cell-associated enterocolitis (IEC-colitis), a rare but serious complication that causes colitis or enterocolitis. #ASH25 #mmsm